Chi Ma

ORCID: 0000-0003-3491-8891
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory mediators and NSAID effects
  • Osteoarthritis Treatment and Mechanisms
  • Peroxisome Proliferator-Activated Receptors
  • Bone Metabolism and Diseases
  • Bone and Joint Diseases
  • Advanced Glycation End Products research
  • Estrogen and related hormone effects
  • Cytokine Signaling Pathways and Interactions

Jishou University
2020-2024

Zhongnan Hospital of Wuhan University
2023

Wuhan University
2023

Hunan Normal University
2014-2020

Osteoarthritis (OA) is an age-related metabolic disease. Low-grade inflammation and oxidative stress are the last common pathway of OA. α-ketoglutarate (α-KG) essential physiological metabolite from mitochondrial tricarboxylic acid (TCA) cycle, with multiple functions, including anti-inflammation antioxidation, exhibits decreased serum levels age. Herein, we aimed to investigate effect mechanism α-KG on We first quantified in human cartilage tissue osteoarthritic chondrocytes induced by...

10.1016/j.redox.2023.102663 article EN cc-by-nc-nd Redox Biology 2023-03-10

Objective Advances made in the past ten years highlight notion that peroxisome proliferator-activated receptors gamma (PPARγ) has protective properties pathophysiology of osteoarthritis (OA). The aim this study was to define roles PPARγ AGEs-induced inflammatory response human chondrocytes. Methods Primary chondrocytes were stimulated with AGEs presence or absence neutralizing antibody against RAGE (anti-RAGE), MAPK specific inhibitors and agonist pioglitazone. expression IL-1, MMP-13,...

10.1371/journal.pone.0125776 article EN cc-by PLoS ONE 2015-05-29

Glucocorticoid-induced osteoporosis (GIOP) is the common reason for secondary osteoporosis. Dendrobine (DEN) major biologically active component of

10.1021/acs.jafc.4c02798 article EN Journal of Agricultural and Food Chemistry 2024-07-21

Advanced glycation end products (AGEs) play a pivotal role in the initiation and progression of osteoarthritis (OA). Peroxisome proliferator-activated receptor-γ (PPARγ) has been shown to exhibit anti-inflammatory anticatabolic properties be protective animal models OA. This study was aimed investigate possible effect PPARγ agonist pioglitazone on AGE-induced chondrocyte damage.Cultured chondrocytes were stimulated with AGEs presence or absence an antibody against receptor for (anti-RAGE),...

10.1159/000369074 article EN Pharmacology 2014-01-01

Abstract Aims : There is a well-established link between OA and diabetes, study have shown that hyperglycemia might play an important role in the occurrence development of OA. Accumulative evidence suggested PPARγ was involved AGEs-related disease, including diabetes The designed to investigate effects on expression chondrocytes whether agonist pioglitazone had chondroprotective effect. Main methods Primary human were incubated with different concentration glucose medium(5.5mM-30mM) presence...

10.21203/rs.3.rs-93188/v1 preprint EN cc-by Research Square (Research Square) 2020-10-21
Coming Soon ...